NCT01746771: A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer |
|
|
| Completed | 1/2 | 44 | RoW | HM781-36B(Poziotinib), NOV120101, Poziotinib, Paclitaxel, Trastuzumab, Herceptin | Hanmi Pharmaceutical Company Limited, National OncoVenture | HER-2 Positive Advanced Gastric Cancer | 08/15 | 08/15 | | |
